Medical device companies are shifting their CEO compensation practices away from equity awards to performance measures based more on returns to shareholders, according to a Morgan Stanley report. Medical device companies are shifting the way they pay their CEOs, moving away from equity-based awards toward compensation pegged to financial metrics that are more aligned with shareholders’ interests, according to a report from Morgan Stanley.
Hey, check out all the engineering jobs. Post your resume today!
